Prior to COVID19, the scale of serious infection was recognised by the UK Government in its plans to address antimicrobial resistance (AMR) and the NHS Long Term Plan.
This, combined with our academic strength in Liverpool, makes infection a priority for Liverpool Health Partners.
As the global experience of COVID19 illustrates, prevention, detection and appropriate treatment of infection can help patients lead healthier lives for longer.
The potential benefit to society of discoveries and advancement in anti-infective research is huge in terms of health and wealth.
There are a number of projects Liverpool Health Partners are currently working on:
There are a number of collaboration opportunities for people to get involved in.